دورية أكاديمية

Severe Acute Respiratory Syndrome Coronavirus 2 and Respiratory Virus Sentinel Surveillance, California, USA, May 10, 2020-June 12, 2021.

التفاصيل البيبلوغرافية
العنوان: Severe Acute Respiratory Syndrome Coronavirus 2 and Respiratory Virus Sentinel Surveillance, California, USA, May 10, 2020-June 12, 2021.
المؤلفون: Sondermeyer Cooksey, Gail L., Morales, Christina, Linde, Lauren, Schildhauer, Samuel, Guevara, Hugo, Chan, Elena, Gibb, Kathryn, Wong, Jessie, Wen Lin, Bonin, Brandon J., Arizmendi, Olivia, Lam-Hine, Tracy, Tzvieli, Ori, McDowell, Ann, Kampen, Kirstie M., Lopez, Denise L., Ennis, Josh, Lewis, Linda S., Oren, Eyal, Hatada, April
المصدر: Emerging Infectious Diseases; Jan2022, Vol. 28 Issue 1, p9-19, 11p, 2 Charts, 4 Graphs, 1 Map
مصطلحات موضوعية: COVID-19, HEALTH boards, POISSON regression
مصطلحات جغرافية: CALIFORNIA
مستخلص: State and local health departments established the California Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Respiratory Virus Sentinel Surveillance System to conduct enhanced surveillance for SARS-CoV-2 and other respiratory pathogens at sentinel outpatient testing sites in 10 counties throughout California, USA. We describe results obtained during May 10, 2020‒June 12, 2021, and compare persons with positive and negative SARS-CoV-2 PCR results by using Poisson regression. We detected SARS-CoV-2 in 1,696 (19.6%) of 8,662 specimens. Among 7,851 specimens tested by respiratory panel, rhinovirus/enterovirus was detected in 906 (11.5%) specimens and other respiratory pathogens in 136 (1.7%) specimens. We also detected 23 co-infections with SARS-CoV-2 and another pathogen. SARS-CoV-2 positivity was associated with male participants, an age of 35-49 years, Latino race/ethnicity, obesity, and work in transportation occupations. Sentinel surveillance can provide useful virologic and epidemiologic data to supplement other disease monitoring activities and might become increasingly useful as routine testing decreases. [ABSTRACT FROM AUTHOR]
Copyright of Emerging Infectious Diseases is the property of Centers for Disease Control & Prevention (CDC) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:10806040
DOI:10.3201/eid2801.211682